Glycosaminoglycan synthesis and secretion by primate arterial smooth muscle have been examined in cell culture. Mass cultures of diploid primate arterial smooth muscle cells were either double labeled with [ssS]sulfate and [3H]acetate or single labeled with [SH]glucosamine for 24 h and glycosaminoglycans were extracted and isolated from the culture medium. Incorporation of labeled precursors into glycosaminoglycan was maximal during stationary phase of smooth muscle cell growth in culture and reduced, but not eliminated during logarithmic growth. The glycosaminoglyeans synthesized and secreted into the culture medium were characterized by differential susceptibility to glycosaminoglycan-degradative enzymes and by cellulose acetate electrophoresis. Both assay procedures indicate that cultured primate arterial smooth muscle cells synthesize principally dermatan sulfate (60%-80% of total), chondroitin sulfate A and/or C (10%-20% of total) and little or no hyaluronic acid (0%-5% of total). This pattern of glycosaminoglycan formation differed significantly from that exhibited by isologous skin fibroblasts cultured under identical conditions. Dermal fibroblasts synthesize and secrete primarily hyaluronic acid (50%-60% of total) with lesser amounts of dermatan sulfate (10%-20% of total) and chondroitin sulfate A and/or C (10%-20% of total). These results indicate that differences exist in proteoglycan metabolism between these two connective tissue-producing cells in vitro, and suggest that the observed pattern of in vitro glycosaminoglycan synthesis by primate arterial smooth muscle cells may be characteristic for this cell type and not a general response to conditions of cell culture.
Although proteoglycans are known to be important constituents of the connective tissues of artery walls (3, 4, 12, 25, 26, 43, 63, 64) , knowledge of their cellular source and metabolism is limited. In the accompanying study (63) , we demonstrate that the smooth muscle of the intima and media of primate arteries is surrounded by numerous proteoglycan granules and suggest that the smooth muscle cell is responsible for the synthesis and secretion of these connective tissue components. Other studies have demonstrated that arterial smooth muscle cells are capable of synthesizing and secreting collagen and elastic fibers in vivo (51) and in vitro (48, 49) confirming their connective tissue-synthetic capacity, but this cell's ability to form proteoglycans has not been definitively established.
In the present study, we have examined the 
Preparation of Smooth Muscle and Fibroblast Cell Cultures
Arterial smooth muscle cell cultures were established by the method of Ross (48, 49) . Strips of intimal medial tissue from the thoracic aorta of l-2-yr old pigtail monkeys (Macaca nemestrina) were r in the Dulbecco-Vogt modification of Eagle's minimal medium supplemented with either 5% or 10% homologous serum. Cells were allowed to grow to confluency, at which time they were trypsinized and passed. Cells were replated at a density of 7.0 • 10' cells/ml in 250-ml Falcon flasks in 10 ml of medium supplemented with 5% pooled homologous serum and allowed to grow to confluency in an atmosphere of 5% CO2 and 95% air at 37~ Cultures in the second to sixth passages were used in all experiments. Previous electron microscope studies of cultures prepared in this manner at saturation density have revealed that all the cells have the ultrastructural characteristics of smooth muscle (49) .
Arterial smooth muscle cell growth curves were established by maintaining parallel cultures in different concentrations of serum as previously described (49, 50) . Equal numbers ( 9 • 10 ~ cells) of trypsin-treated smooth muscle cells were plated, with a Cornwall syringe, into 60-ram Falcon plastic petri dishes (Falcon Plastics, Div. of B.-D. Laboratories, Los Angeles, Calif.) and maintained in medium containing 1% pooled homologous serum for 7 days (medium changed three times a week). On day 7, one-half of the cultures received medium containing 5% pooled homologous serum while the other half were transferred to a medium containing no serum.
t This study uses extraction procedures which remove and isolate the glycosaminoglycan portion of the proteoglycan for analysis. Although the protein moiety of the proteoglycan was not analyzed, it can be assumed that analysis of glycosaminoglycan synthesis reflects proteoglycan synthesis by these cells.
Sufficient numbers of dishes of cells were maintained to determined a growth curve for a period of at least 16 days. Cell numbers were determined by counting in a Fuchs-Rosenthal chamber. Mean and standard errors were calculated for each point in the growth curve.
Skin fibroblast cultures were established from abdominal skin from the same donor animal. Pieces of skin were minced into 2-ram squares and treated in the same manner as the smooth muscle explants. Subsequent to trypsinization, fibroblasts were grown in either 5% (M42) or 4% (M52) homologous serum. After labeling, the medium was removed and cell counts were determined as previously described. The labeled medium was extracted for glycosaminoglycans by the procedure of Nameroff and Holtzer (44) . Briefly, this procedure consists of boiling the samples for 5 min, followed by pronase digestion (0.5 mg/ml in 0.2 M Tris-HCI buffer, pH 8.0) for 18 h at 60~ Ice-cold tricholoroacetic acid (TCA) was added to a final concentration of 10% and the precipitates were removed by centrifugation. The supernates were exhaustively dialyzed at 4~ initially against 0.01 M solutions of the appropriately unlabeled compounds and finally against distilled H 20. The isotopically labeled material was concentrated by contact dessication (Aquacide, Calbiochem, San Diego, Calif.) and portions were taken for enzyme-subtraction digestion assays and for electrophoresis.
Measurement of Glycosaminoglycan Synthesis and Secretion
To eliminate the possibility of nonspecific trapping of the isotope(s) in the culture medium, as well as to check for possible cell-free synthesis (i.e. sulfation), parallel flasks containing culture medium with no cells were labeled and the medium was extracted for glycosaminoglycans as previously described.
Measurement of the Rate of Glycosaminoglycan Synthesis During Log and Stationary Phase of Growth
To determine whether glycosaminoglycan synthesis occurred in both dividing and nondividing cell populations, culture dishes were double labeled with [ssS]sulfate and [all]acetate (20 t~Ci/dish) for 48 h on days 5, 7, 10, 12, and 17 of the growth curve. The culture medium from each of these time intervals was extracted for glycosaminoglycans as previously described and specific activities were determined (dpm/10' cells).
Identification of Isolated G lycosaminoglycans

ENZYME
DIGESTION-SUBTRACTION METHOD~
To examine the typas of glycosaminoglycan synthesized and secreted by arterial smooth muscle cells in cultu~, we employed an assay system based upon the differential susceptibility of different glycosaminoglycans to specific polysaccharidascs according to the scheme of Toole and Gross (60 After incubation in all experiments, equal aliquots (1.0 ml) of the digestion products were separated on a column of Sephadex G-25, fine (2.5 • 90 cm), collected as 3.0-ml fractions, and assayed for radioactivity with Aquasol (New England Nuclear) in a Packard Tri-Carb scintillation counter. By determining the percentage of activity retarded on G-25 as a function of total activity applied to the column, it is possible to obtain an estimate of the types of glycosaminoglycans present in the sample (A. Dorfman, personal communication). Using [aH]glucosamine or [aHlaceta~ as precursors, the percentage of activity retarded in the leech hyaluronidase digests serves an an estimate of the amount of hyaluronic acid present since this enzyme specifically degrades hyaluronic acid (A. Balazs, personal communication). By using [~S]sulfate as a precursor, the retarded fraction from the testicular hyaluronidase digest provides an estimate of the amount of chondroitin sulfate A and C in the sample (52) . Subtraction of the amount of 86S activity retarded in the testicular hyaluronidase digests from the ssS activity retarded in the chondroitinase ABC digests provides an estimate of the amount of dermatan sulfate present, since both of these enzymes degrade chondroitin sulfate A and C but only chondroitinase ABC fully degrades dermatan sulfate (52) . The activities of these enzymes were checked by incubating them with glycosaminoglyean standards (Seikagaku Fine Biochemicals, Tokyo, Japan) and by performing uronic acid determinations (10) on the digestion products collected as 3.0-ml fractions from Sephadex G25.
CELLULOSE ACETATE ELECTROPHORESIS:
To confirm the results obtained by using the enzyme digestion subtraction method, additional aliquots of isotopically labeled nondialyzable, TCA-soluble material isolated from the culture medium were mixed with 50 ~.g of standard hyaluronic acid, chondroitin sulfate C, and dermatan sulfate, and electrophorescd on cellulose acetate paper (Geiman Instrument Co., Ann Arbor, Mich.) in 0.1 M pyridine-formate buffer, pH 3.0, at 100 V for 60 min at room temperature (44) . After drying, the strips were stained with 0. i % toluidine blue in 30% methanol to identify the position of the carriers. The strips were air dried, cut into 0.5-cm fractions, and assayed for radioactivity using Aquasol (New England Nuclear) in a Packard Tri-Carb liquid scintillation counter. (Table I ). Since the majority of the activity was present in the medium (~85%) as compared to the cell layer (~15%), only the labeled medium was analyzed for newly synthesized glycosaminoglycans. Virtually all the activity present in the TCA-soluble material isolated from control flasks (medium incubated with isotopic precursors in the absence of cells) was dialyzable.
RESULTS
Proteoglycan Synthesis and Secretion by Primate A rterial Smooth Muscle Cells in Vitro
To obtain an estimate of the types of glycosaminoglycans present in these medium isolates, parallel aliquots were digested with glycosaminoglycanspecific degradative enzymes and the digestion products separated on Sephadex G-25 columns. Approximately 95% of the activity present in the [SH]acetate-and [3H]glucosamine-labeled isolates emerged in the void volume after leech hyaluronidase digestion, indicating minimal degradation ( Fig. 1 ). 10-20% of the [ssS]sulfate activity and slightly less Jail]acetate or [SH]glucosamine activity emerged slightly behind the void volume in the testicular hyaluronidase digests, indicating partial degradation (Fig. 2) . 80-90% of the [asS]sulfate activity and 60-80% of the [SH]acetate or [SH]glucosamine activity in the medium isolates emerged as a distinct second peak behind the void volume after chondroitinase ABC digestion, indicating extensive degradation (Fig. 3) .
By calculating the percentage of activity retarded on Sephadex G-25 columns in each digest as a function of total activity applied to the column and using the enzyme digestion subtraction method, we are able to make the following esti- mates of the types of glycosaminoglycans synthesized and secreted by primate arterial smooth muscle cells in vitro: hyaluronic acid (0 5%); chondroitin sulfate A and/or C (10-20%); dermatan sulfate (60-80%); other sulfated glycosaminoglycans (10% or less). These values represent mean ranges in four separate experiments.
To verify this assay for glycosaminoglycan identification, parallel portions of labeled TCAsoluble, nondialyzable material isolated from the smooth muscle cell culture medium were charac-4000-,*,
Froction No terized by cellulose acetate electrophoresis against known glycosaminoglycan standards. By spotting approximately 20 #g of each standard, it was possible to obtain clear separation of hyaluronic acid, dermatan sulfate, and chondroitin sulfates A and/or C (chondroitin sulfate A migrates together with chondroitin sulfate C and it is not possible to separate these isomers by using the conditions of electrophoresis in this study). The major peak of radioactivity in all electrophoresed portions corre-sponded to the dermatan sulfate standard (60-70% of the total activity), with lesser peaks associated with the chondroitin sulfate C standard (10-40%) and several minor peaks which migrated behind dermatan sulfate (0-18%) (Fig. 4) .
Although there is slight variation in the relative amounts of glycosaminoglycans synthesized and secreted by arterial smooth muscle cells in vitro as determined by these two assay systems, both assays were reproducible in several different experiments and indicate that the major glycosaminoglycan synthesized and secreted by these cells is dermatan sulfate (at least 60% of total). Furthermore, these results indicate that these cells make little or no hyaluronic acid under the culture conditions used in these experiments.
Synthesis and Secretion of Giycosaminoglycans by Primate Arterial Smooth Muscle Cells During Log and Stationary Phases o f Growth
To determine whether glycosaminoglycan synthesis could occur in both actively growing and quiescent cell populations, arterial smooth muscle Table I1 demonstrate that the synthesis and secretion is maximal during stationary phases of growth and decreases to approximately onethird the normal value by 3-4 days after the cells have been stimulated to divide by the addition of 5% serum (Fig. 5) . This reduced rate of synthesis was evident throughout the culture period as long as the cells grew logarithmically. The types of glycosaminoglycans synthesized during these different phases of growth were not determined because the radioactivity in the medium isolates was too low for analysis. Additional experiments using a greater number of cells are currently in progress to investigate the pattern of glycosaminoglycan synthesis by arterial smooth 
... ) or 5% homologous serum ( ). Cultures were double labeled with [35S]sulfate and
[all]acetate for 48 h on days 5, 7, 10, 12, and 17 and the medium was extracted for glycosaminoglycans at each of these times (see Table II ). muscle cells during their different growth phases in culture.
Pattern of Giycosaminoglycan Synthesis by Arterial Smooth Muscle Cells vs. Skin Fibroblasts
To determine whether the observed pattern of glycosaminoglycan synthesis was characteristic of arterial smooth muscle cells or represented a general response displayed by other types of connective tissue cells in culture, we compared the pattern of glycosaminoglycan synthesis between arterial smooth muscle cells and dermal fibroblasts derived from the same donor under the identical culture conditions.
Using (Table III) . Approximately 60% of the [SH]acetate activity in the skin fibroblast culture medium was retarded on Sephadex G-25 after leech hyaluronidase digestion (Fig. 6) . Testicular hyaluronidase caused approximately 72% of the [SH]acetate activity in the medium isolates to elute in the retarded fractions (Fig. 7) , while 85% of the [SH]acetate activity was retarded after condroitinase ABC digestion (Fig. 8) . It should be noted that testicular hyaluronidase and chondroitinase ABC degrade hyaluronic acid in addition to their specific chondroitin sulfate isomers (52) . Using the enzyme digestion subtratction method, we are able to make the following estimates as to the types of glycosaminoglycans synthesized and secreted by skin fibroblasts in vitro: hyaluronic acid (50-60%); chondroitin sulfate A and/or C (10-20%); dermatan sulfate (10-20%); other (10-20%). This pattern of in vitro glycosaminoglycan synthesis by skin 
DISCUSSION
Evidence for Glycosaminoglycan Synthesis and Secretion In Vitro
In the present study, we have demonstrated that cell cultures of primate arterial smooth muscle, prepared from l-2-yr old pigtail monkey (M. nemestrina) thoracic aortas synthesize and secrete significant quantities of sulfated glycosaminoglycans into the culture medium. The finding that approximately 90% of the [ssS]sulfate-labeled TCA-soluble, nondialyzable material isolated from the medium of these cultures was degraded by chondroitinase ABC indicates that the majority of the [86S]sulfate was incorporated into newly synthesized glycosaminoglycans. Approximately the same percentage of [3sS]sulfate activity was associated with standard sulfated glycosaminoglycans when the medium isolates were subjected to electrophoresis, confirming the results obtained after chondroitinase ABC digestion and indicating that sulfate is a relatively specific precursor for examination of sulfated glycosaminoglycan synthesis by these cells. Whether the remaining 10% of the 35S label was present in chondroitinase ABC-resistant glycosaminoglycans (heparan sulfate and/or keratosulfate), or incorporated into other macromolecules such as sulfated giycoproteins (55), was not determined in this study.
The incorporation of [SH]acetate and [SH]glucosamine into TCA-soluble, nondialyzable material isolated from the medium of these cultures and the subsequent degradation of this labeled material by chondroitinase ABC further indicate that total glycosaminoglycan synthesis occurred, and not merely sulfation of pre-existing nonsulfated glycosaminoglycans (19, 30, 47, 58) . The observation that 60-80% of the isolated [SH]acetate and [SH]glucosamine activity in the medium coelectrophoresed with sulfated glycosaminoglycan standards provides further support for this conclusion.
Our data further demonstrate that cultures in logarithmic growth continue to synthesize glycosaminoglycans, although at a reduced rate. These observations suggest that both dividing and nondiriding cells synthesize and secrete glycosaminoglycans and support previous studies of in vitro glycosaminoglycan synthesis by corneal fibroblasts (7) and chondrocytes (6, 28, 29, 46) . However, we did not determine the percentage of cells actively dividing, hence it is possible that the lower rate of synthesis during log growth reflects synthesis by quiescent cells that are not synthesizing DNA. Further studies would be necessary to exclude this possibility.
Correlation of In Vitro Pattern of Glycosaminoglycan Synthesis with In Vivo Observations
The observation that cultured primate arterial smooth muscle cells form principally one type of sulfated glycosaminoglycan, dermatan sulfate, and lesser amounts of chondroitin sulfate A and/or C is of interest, because it has been reported that dermatan sulfate comprises only 10-20% of the total glycosaminoglycans present in artery walls, whereas chondroitin sulfate A and/or C are present in much greater amounts (3, 9, 12, 16, 21, 25, 26, 43, 53) . There are several possible explanations for this apparent discrepancy. It is conceivable that the in vitro pattern of synthesis may be a response by the smooth muscle cells to the special conditions of cell culture, since a variety of culture conditions are known to exert different effects on glycosaminoglycan synthesis by other cell types (8, 32, 36, 57) . Dermatan sulfate increases markedly in arteries that develop intimal lesions resulting from trauma (16) or after extensive lipid infiltration (27) . These observations suggest that dermatan sulfate synthesis may be a response by arterial smooth muscle cells to some form of mechanical or chemical stress. On the other hand, since experimentally induced arterial intimal hyperplasia is characterized by extensive focal smooth muscle proliferation, it is also possible that the culture conditions in which cells are rapidly proliferating are analagous to in vivo intimal hyperplasia. Thus, the pattern of in vitro glycosaminoglycan synthesis may be a characteristic of proliferating cells.
It is also possible that this pattern of glycosaminoglycan synthesis reflects the particular state of development of the arterial smooth muscle cells. For example, it is well documented that in some developmental systems, such as cornea (37, 62) , cartilage (24, 35, 41, 44, 54, 59) , and heart (13, 31) , the pattern of in vitro and in vivo glycosaminoglycan synthesis changes with age and degree of development. In the primate aorta, the amount of dermatan sulfate has been shown to increase with age with a concomitant decrease in chondroitin sulfate A and/or C (25, 53) . It is noteworthy that our arterial smooth muscle cell cultures were established from I-2-yr old monkeys and that the cells had been passed an average of three to four times. Thus, it is possible that dermatan sulfate synthesis by these cells may reflect an age-dependent (number of cell doublings) biosynthetic program of these macromolecules (18) . It would be of interest to compare the pattern of glycosaminoglycan synthesis by cultures established from embryonic aortas with that observed by cells from older donors or cells that had gone through a greater number of generations in culture.
Toole and Lowther (61) have demonstrated that dermatan sulfate proteoglycan isolated from skin and heart valves exhibits the ability to form precipitates when mixed with tropocollagen at physiological pH and ionic strengths. These observations have led to the suggestion that one possible function of dermatan sulfate is to participate in the formation and orientation of collagen fibrils. Primate arterial smooth muscle cells do synthesize and secrete collagen in vitro (J. Burke, unpublished observations) and it may be that the synthesis of dermatan sulfate by these cells is closely tied to collagen fibrillogenesis in these cultures. Collagen as well as chondromucoprotein are known to influence the synthesis of glycosaminoglycans by other cell types (20, 38, 39, 45) .
It is also possible that other types of cells present in the artery wall synthesize one class of glycosaminoglycan while the smooth muscle cells synthesize another. Recent experiments have demonstrated that cultured rabbit aortic endothelial cells form significant quantities ofchondroitin sulfate A and considerably less dermatan sulfate (5) . It remains to be determined whether primate endothelial cells exhibit a similar pattern of glycosaminoglycan synthesis.
To our knowledge, the only other cell type known to synthesize such large quantitites of dermatan sulfate in vitro is the skin fibroblast derived from patients with the Hurler's or Hunter's syndrome (33, 34) . The large amount of dermatan sulfate associated with these fibroblasts has been shown to be due to the lack of turnover of this macromolecule by these cells since they do not produce the enzyme necessary to degrade dermatan sulfate (L-iduronidase) (1) . There are no data on the ability of arterial smooth muscle cells to synthesize glycosaminoglycan-degradative enzymes in vitro. In contrast, Hermein et al. (17) recently demonstrated that dermatan sulfate exhibited the most rapid turnover of all of the glycosaminoglycans tested in the rat aorta, a species notably resistant to atherosclerosis. Thus, even though arterial smooth muscle cells synthesize large quantities of dermatan sulfate, this macromolecule may be degraded at a rapid rate in noninjured arteries, preventing its accumulation. However, in species that are susceptible to lesion formation, dermatan sulfate may turn over more slowly, explaining its accumulation in lesions such as the human atherosclerotic fatty streaks (27) . There are at present no data on the in vivo content of glycosaminoglycans in the nonhuman primate artery (M. nemestrina). Further studies are needed to determine whether differences in turnover of glycosaminoglycans are responsible for the differential accumulation of these macromolecules in the artery wall.
The function of dermatan sulfate in the artery wall needs to be clarified. Berenson (2) demonstrated that dermatan sulfate isolated from bovine aorta exhibits antithrombotic activity, as has been demonstrated for dermatan sulfate from other sources (15) . Thus, one possible function of this macromolecule in the artery wall may be in the prevention of thrombosis (11) .
The importance of dermatan sulfate in the artery wall has recently been emphasized by Iverius (22, 23) who has demonstrated that dermatan sulfate exhibits the greatest affinity for binding with low density lipoproteins at physiological pH and ionic strength of all of the glycosaminoglycans tested. His observations suggest a role for dermatan sulfate in acting as a trap or sink for lipid deposits that form in the lesions of atherosclerosis.
Arterial Smooth Muscle vs.
Dermal Fibroblasts
Whatever the reason for dermatan sulfate synthesis by primate arterial smooth muscle cells in vitro, this pattern of synthesis is clearly different from that exhibited by primate skin fibroblasts cultured under identical conditions. The large amount of hyaluronic acid produced by dermal fibroblasts in this study is consistent with other studies which have shown hyaluronic acid to be the major glycosaminoglycan synthesized by cultures of various types of fibroblasts, including dermal fibroblasts (see, for reviews, references 40 and 42) . The large amount of hyaluronic acid and the small amount of dermatan sulfate produced by dermal fibroblasts contrast sharply with the arterial smooth muscle cells which demonstrate an opposite pattern, namely the formation of large quantities of dermatan sulfate and relatively little hyaluronic acid. This difference, coupled with other morphological differences in their pattern of in vitro growth and in their fine structure, provides an additional means to discriminate between these two cell types in culture.
The authors wish to express appreciation to Dr. Mark Nameroff, Department of Biological Structure, University of Washington School of Medicine, for his advice and help in learning to do the glycosaminoglycan analysis. 136.) have demonstrated that dermatan sulfate is the major aortic glycosaminoglycan present in the nonhuman primate rhesus monkey unlike other species where chondroitin sulfate A and/or C is the predominant aortic glycosaminoglycan. These findings indicate that the large amount of dermatan sulfate synthesized and secreted by cultured nonhuman primate arterial smooth muscle cells observed in the present study may reflect the pattern of glycosaminoglycan synthesis that occurs in intact arteries of nonhuman primates.
